BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32276009)

  • 21. Dendritic cells that highly express SOCS1 induce T-cell hypo-responsiveness and prolong islet allograft survival.
    Lu X; Chen M; Xue Z; Zhang X; Xu J; Wu L; Deng R; Ma Y
    Cell Immunol; 2017 Apr; 314():36-41. PubMed ID: 28215626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effects of a novel lipid-soluble extract from
    Zhang M; Zhang H; Yu Y; Huang H; Li G; Xu C
    Oncol Lett; 2017 Apr; 13(4):2121-2128. PubMed ID: 28454371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1.
    Saudemont A; Hamrouni A; Marchetti P; Liu J; Jouy N; Hetuin D; Colucci F; Quesnel B
    Cancer Res; 2007 May; 67(9):4491-8. PubMed ID: 17483365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced immunotherapeutic effect of modified HPV16 E7-pulsed dendritic cell vaccine by an adeno-shRNA-SOCS1 virus.
    Zhu Y; Zheng Y; Mei L; Liu M; Li S; Xiao H; Zhu H; Wu S; Chen H; Huang L
    Int J Oncol; 2013 Oct; 43(4):1151-9. PubMed ID: 23877655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulated SOCS1 expression activates the JAK1/STAT1 pathway and promotes polarization of macrophages into M1 type.
    Liang YB; Tang H; Chen ZB; Zeng LJ; Wu JG; Yang W; Li ZY; Ma ZF
    Mol Med Rep; 2017 Nov; 16(5):6405-6411. PubMed ID: 28901399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between methylation of tumor suppressor gene SOCS1 and acute myeloid leukemia.
    Zhang XH; Yang L; Liu XJ; Zhan Y; Pan YX; Wang XZ; Luo JM
    Oncol Rep; 2018 Aug; 40(2):1008-1016. PubMed ID: 29916533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. As
    Wu D; Dong W; Fang K; Wang M
    Technol Cancer Res Treat; 2019; 18():1533033819896806. PubMed ID: 31868118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of the exopolysaccharide from an anamorph of Cordyceps sinensis on dendritic cell sarcoma (DCS) cell line.
    Song D; He Z; Wang C; Yuan F; Dong P; Zhang W
    Eur J Nutr; 2013 Mar; 52(2):687-94. PubMed ID: 22610670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of SOCS1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study.
    Yu SJ; Long ZW
    Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway.
    Maruoka M; Kedashiro S; Ueda Y; Mizutani K; Takai Y
    J Biol Chem; 2017 Apr; 292(17):6895-6909. PubMed ID: 28258213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplifying IFN-γ Signaling in Dendritic Cells by CD11c-Specific Loss of SOCS1 Increases Innate Immunity to Infection while Decreasing Adaptive Immunity.
    Alice AF; Kramer G; Bambina S; Baird JR; Bahjat KS; Gough MJ; Crittenden MR
    J Immunol; 2018 Jan; 200(1):177-185. PubMed ID: 29150567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
    Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
    Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of SOCS1 Gene on Growth Inhibition of Acute Myeloid Leukemia Cells Mediated by JAK2/STAT Signaling Pathway].
    Zhang XH; Luo JM; Yang L; Liu XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1496-1503. PubMed ID: 33067944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Panchvalkala, a traditional Ayurvedic formulation, exhibits antineoplastic and immunomodulatory activity in cervical cancer cells and C57BL/6 mouse papilloma model.
    Aphale S; Shinde K; Pandita S; Mahajan M; Raina P; Mishra JN; Kaul-Ghanekar R
    J Ethnopharmacol; 2021 Nov; 280():114405. PubMed ID: 34260879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research of SOCS1 silent DC vaccine on laryngocarcinoma therapy].
    Yuan Y; Wang XF; Zhang Y; Wang JY; Luan N
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Feb; 26(4):169-73. PubMed ID: 22568257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential Induction of SOCS Isoforms by
    Chandrakar P; Parmar N; Descoteaux A; Kar S
    J Immunol; 2020 Feb; 204(3):596-610. PubMed ID: 31882519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic cytotoxic effects of a combined treatment of a
    Zhang M; Yu Y; Zhang H; Huang H; Cai Q; Kang Y; Li G; Xu C
    Oncol Lett; 2017 Jun; 13(6):4748-4754. PubMed ID: 28588727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
    Heo MB; Cho MY; Lim YT
    Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aqueous extracts from cultivated Cistanche deserticola Y.C. Ma as polysaccharide adjuvant promote immune responses via facilitating dendritic cell activation.
    Feng S; Yang X; Weng X; Wang B; Zhang A
    J Ethnopharmacol; 2021 Sep; 277():114256. PubMed ID: 34062250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing SOCS1 via Liposome-Packed siRNA Sustains TLR4-Ligand Adjuvant.
    Hildebrand D; Metz-Zumaran C; Jaschkowitz G; Heeg K
    Front Immunol; 2019; 10():1279. PubMed ID: 31214204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.